Vosevi ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatite c, crônica - antivirais para uso sistêmico - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (consulte as secções 4. 2, 4. 4 e 5.

Epclusa ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

epclusa

gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatite c, crônica - antivirais para uso sistêmico - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 e 5.

Sovaldi ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

sovaldi

gilead sciences ireland uc - sofosbuvir - hepatite c, crônica - antivirais para uso sistêmico - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 e 5. para o vírus da hepatite c (vhc) genótipo atividade específica, consulte as secções 4. 4 e 5. sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 e 5. para o vírus da hepatite c (vhc) genótipo atividade específica, consulte as secções 4. 4 e 5.

Harvoni ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

harvoni

gilead sciences ireland uc - ledipasvir, sofosbuvir - hepatite c, crônica - antivirais para uso sistêmico - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 e 5. para o vírus da hepatite c (vhc) genótipo-actividade específica, consulte as secções 4. 4 e 5.

HARVONI ব্রাজিল - পর্তুগীজ - ANVISA (Agência Nacional de Vigilância Sanitária)

harvoni

gilead sciences farmaceutica do brasil ltda - sofosbuvir, ledipasvir - antivirais de aÇÃo direta